<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04056676</url>
  </required_header>
  <id_info>
    <org_study_id>SI 475/2019</org_study_id>
    <nct_id>NCT04056676</nct_id>
  </id_info>
  <brief_title>Analgesic Effect of Adding Thoracic Paravertebral Nerve Blocks to Modified PEC Block in Breast Cancer Surgery</brief_title>
  <official_title>Analgesic Effect of Adding Thoracic Paravertebral Nerve Blocks to Modified PEC Block in Breast Cancer Surgery, Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare efficacy and safety of adding thoracic paravertebral nerve blocks to modified PEC
      block versus modified PEC block only in breast cancer surgery. This study evaluate systemic
      opioid requirement in 48 hours in primary outcome and the analgesic profile ( pain score at
      rest and on shoulder movement), opioid-related side effects and nerve blocks complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Regional anesthesia has been used and studied extensively in breast surgery as an
      opioid-sparing strategy, with block of the intercostal supply by thoracic paravertebral block
      (TPVB) becoming a popular technique.

      This prospective randomized controlled trial is aimed to study the proper regional nerve
      block technique to reach the postoperative opioid-free requirement modality for breast cancer
      surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>group A Intraoperative modified PEC block only group B Preoperative thoracic paravertebral block plus intraoperative modified PEC block</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Randomized group of patient is identified and sealed in envelope. There is not written group in anesthetic record. Postoperative outcomes are assessed by Acute Pain Service nurse or a resident (co-investigator who blinds to the technique).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative fentanyl consumption</measure>
    <time_frame>at postoperative 24 hours</time_frame>
    <description>Cumulative fentanyl consumption within postoperative 24 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative fentanyl consumption</measure>
    <time_frame>at postoperative 48 hours</time_frame>
    <description>Cumulative fentanyl consumption within postoperative 24-48 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative fentanyl use</measure>
    <time_frame>Intraoperation</time_frame>
    <description>Dosage of intraoperative fentanyl usage in micrograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score at rest</measure>
    <time_frame>at postoperative 0 hour (PACU arrival)</time_frame>
    <description>Numeric rating score 0-10 (0= no pain, 10= worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score at rest</measure>
    <time_frame>at postoperative 30 min (in PACU)</time_frame>
    <description>Numeric rating score 0-10 (0= no pain, 10= worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score at rest</measure>
    <time_frame>at postoperative 1 hour (in PACU)</time_frame>
    <description>Numeric rating score 0-10 (0= no pain, 10= worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score at rest</measure>
    <time_frame>Postoperative 6 hour (at ward)</time_frame>
    <description>Numeric rating score 0-10 (0= no pain, 10= worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score at rest</measure>
    <time_frame>Postoperative 12 hour (at ward)</time_frame>
    <description>Numeric rating score 0-10 (0= no pain, 10= worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score at rest</measure>
    <time_frame>Postoperative 18 hour (at ward)</time_frame>
    <description>Numeric rating score 0-10 (0= no pain, 10= worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score at rest</measure>
    <time_frame>Postoperative 24 hour (at ward)</time_frame>
    <description>Numeric rating score 0-10 (0= no pain, 10= worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score on shoulder movement</measure>
    <time_frame>Postoperative 1 hour (at PACU)</time_frame>
    <description>Numeric rating score ((0= no pain, 10= worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score on shoulder movement</measure>
    <time_frame>Postoperative first day (at ward)</time_frame>
    <description>Numeric rating score ((0= no pain, 10= worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score on shoulder movement</measure>
    <time_frame>Postoperative second day (at ward)</time_frame>
    <description>Numeric rating score ((0= no pain, 10= worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First time to fentanyl requirement by IV PCA</measure>
    <time_frame>Within 24 hours</time_frame>
    <description>time to require fentanyl patient-controlled intravenous analgesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients presenting with opioid-related adverse effects</measure>
    <time_frame>Within 48 hours</time_frame>
    <description>adverse effects include postoperative nausea, vomiting, dizziness, pruritus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients presenting with nerve block complications</measure>
    <time_frame>Within 48 hours</time_frame>
    <description>nerve block complications include pneumothorax, hypotension, local anesthetic systemic toxicity, Horner syndrome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>From preoperative admission until hospital discharge</time_frame>
    <description>Number of hospital admission days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's satisfaction scale score</measure>
    <time_frame>At postoperative 48 hours</time_frame>
    <description>Satisfaction scale score 0-10 (0= highly unsatisfied, 10= highly satisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness analysis</measure>
    <time_frame>Within 48 hours</time_frame>
    <description>Cost of adding nerve block and postoperative pain score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Breast Cancer Female</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Intraoperative modified PEC block only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraoperative modified PEC block with 0.5% bupivacaine 20 ml plus adrenaline 100 ug by surgeon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adding preoperative thoracic paravertebral nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preoperative thoracic paravertebral nerve block with 0.5% bupivacaine 20 ml plus adrenaline 100 ug and intraoperative modified PEC block with 0.5% bupivacaine 20 ml plus adrenaline 100 ug by surgeon</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracic paravertebral block under ultrasound guidance</intervention_name>
    <description>Ultrasound-guided thoracic paravertebral blocks in T2, T4 level</description>
    <arm_group_label>Adding preoperative thoracic paravertebral nerve block</arm_group_label>
    <other_name>USG-TPVB</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraoperative modified PEC block</intervention_name>
    <description>Pectoral nerve block by surgeon under direct vision after total mastectomy</description>
    <arm_group_label>Adding preoperative thoracic paravertebral nerve block</arm_group_label>
    <arm_group_label>Intraoperative modified PEC block only</arm_group_label>
    <other_name>Modified PEC block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>GA with ETT</intervention_name>
    <description>General anesthesia with endotracheal intubation</description>
    <arm_group_label>Adding preoperative thoracic paravertebral nerve block</arm_group_label>
    <arm_group_label>Intraoperative modified PEC block only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) grade I-III

          -  Aged ≥ 18-80 years old

          -  Elective unilateral total mastectomy with sentinel lymph node biopsy or lymph node
             dissection

        Exclusion Criteria:

          -  Patient refusal

          -  Language barrier or inability to communicate with the operating team

          -  Allergy to local anesthetic

          -  Bleeding disorder

          -  Previous breast surgery or thoracic radiation therapy

          -  BMI ≥ 30

          -  Patient who can not understand the proper use of intravenous patient-controlled
             analgesia machine or who has the problem with communication

          -  Chronic pain patient
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suwimon Tangwiwat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suwimon Tangwiwat, MD</last_name>
    <phone>66816456167</phone>
    <email>stangwiwat@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok Noi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suwimon Tangwiwat, M.D</last_name>
      <phone>(66)81-645-6167</phone>
      <email>stangwiwat@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Missair A, Cata JP, Votta-Velis G, Johnson M, Borgeat A, Tiouririne M, Gottumukkala V, Buggy D, Vallejo R, Marrero EB, Sessler D, Huntoon MA, Andres J, Casasola OL. Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special article. Reg Anesth Pain Med. 2019 Jan;44(1):13-28. doi: 10.1136/rapm-2018-000001. Review.</citation>
    <PMID>30640648</PMID>
  </reference>
  <reference>
    <citation>Woodworth GE, Ivie RMJ, Nelson SM, Walker CM, Maniker RB. Perioperative Breast Analgesia: A Qualitative Review of Anatomy and Regional Techniques. Reg Anesth Pain Med. 2017 Sep/Oct;42(5):609-631. doi: 10.1097/AAP.0000000000000641. Review.</citation>
    <PMID>28820803</PMID>
  </reference>
  <reference>
    <citation>Wynne R, Lui N, Tytler K, Koffsovitz C, Kirwa V, Riedel B, Ryan S. The Trajectory of Postoperative Pain Following Mastectomy with and without Paravertebral Block. Pain Manag Nurs. 2017 Aug;18(4):234-242. doi: 10.1016/j.pmn.2017.03.003. Epub 2017 Jun 7.</citation>
    <PMID>28601480</PMID>
  </reference>
  <reference>
    <citation>Syal K, Chandel A. Comparison of the post-operative analgesic effect of paravertebral block, pectoral nerve block and local infiltration in patients undergoing modified radical mastectomy: A randomised double-blind trial. Indian J Anaesth. 2017 Aug;61(8):643-648. doi: 10.4103/ija.IJA_81_17.</citation>
    <PMID>28890559</PMID>
  </reference>
  <reference>
    <citation>Terkawi AS, Tsang S, Sessler DI, Terkawi RS, Nunemaker MS, Durieux ME, Shilling A. Improving Analgesic Efficacy and Safety of Thoracic Paravertebral Block for Breast Surgery: A Mixed-Effects Meta-Analysis. Pain Physician. 2015 Sep-Oct;18(5):E757-80. Review.</citation>
    <PMID>26431130</PMID>
  </reference>
  <reference>
    <citation>Klein SM, Bergh A, Steele SM, Georgiade GS, Greengrass RA. Thoracic paravertebral block for breast surgery. Anesth Analg. 2000 Jun;90(6):1402-5.</citation>
    <PMID>10825328</PMID>
  </reference>
  <reference>
    <citation>Bashandy GM, Abbas DN. Pectoral nerves I and II blocks in multimodal analgesia for breast cancer surgery: a randomized clinical trial. Reg Anesth Pain Med. 2015 Jan-Feb;40(1):68-74. doi: 10.1097/AAP.0000000000000163.</citation>
    <PMID>25376971</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 8, 2019</study_first_submitted>
  <study_first_submitted_qc>August 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2019</study_first_posted>
  <last_update_submitted>August 12, 2019</last_update_submitted>
  <last_update_submitted_qc>August 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Suwimon Tangwiwat</investigator_full_name>
    <investigator_title>Assistant professor, Department of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Postoperative pain</keyword>
  <keyword>Thoracic paravertebral block</keyword>
  <keyword>Modified PEC block</keyword>
  <keyword>Breast cancer</keyword>
  <keyword>Total mastectomy with sentinel lymph node clearance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

